Abstract
Topical therapies are the mainstay of treatment for psoriasis vulgaris. The fixed combination of calcipotriol (Cal) 50 μg/g plus betamethasone 0.5 mg/g (as dipropionate; BD) is a first-line topical treatment and available as a gel or ointment. The use of these fixed combination products was compared in PRO-long, a long-term noninterventional study, for which interim results (4 and 12 weeks) have previously been reported. To describe and compare patients' perspectives on the fixed combination gel and ointment formulations; to include efficacy, adherence behaviour, treatment satisfaction and health-related quality of life (HRQoL) aspects during long-term real-life psoriasis management. PRO-long was a multicentre, prospective, observational, 52-week study of patients prescribed fixed combination Cal/BD gel or ointment in clinical practice. For final analysis the following were assessed at weeks 24, 36 and 52: differences in the proportion of patients with 'mild'/'very mild' disease according to patient's global assessment of disease severity, adherence behaviour, treatment satisfaction (nine-item treatment satisfaction questionnaire for medication) and HRQoL (Skindex-29). Patients (n = 328) were prescribed once-daily Cal/BD gel (n...Continue Reading
References
Nov 26, 1997·Archives of Dermatology·M M ChrenS J Zyzanski
Aug 25, 1999·Journal of the American Academy of Dermatology·S R RappD M Reboussin
Jul 29, 2004·Journal of the American Academy of Dermatology·Christie L CarrollRajesh Balkrishnan
Oct 20, 2004·The British Journal of Dermatology·C L CarrollR Balkrishnan
May 6, 2005·The New England Journal of Medicine·Michael P Schön, W-Henning Boehncke
Aug 5, 2005·The New England Journal of Medicine·Lars Osterberg, Terrence Blaschke
Aug 27, 2005·The New England Journal of Medicine·Miguel G Madariaga
Nov 4, 2005·The New England Journal of Medicine·Ronald J Campbell
Dec 14, 2005·American Journal of Clinical Dermatology·Alexa B KimballYing Wu
Dec 21, 2005·Archives of Dermatology·Joel M GelfandDavid J Margolis
May 19, 2006·Dermatology : International Journal for Clinical and Investigative Dermatology·Torsten Schäfer
May 15, 2007·Journal of the American Academy of Dermatology·Steven R FeldmanRajesh Balkrishnan
Jul 31, 2007·Lancet·Christopher Em Griffiths, Jonathan Nwn Barker
Oct 5, 2007·Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology·Oleg E AkilovTayyaba Hasan
Apr 22, 2008·Journal of the American Academy of Dermatology·Alan MenterReva Bhushan
Sep 13, 2008·Dermatology : International Journal for Clinical and Investigative Dermatology·T A LugerN H Shear
Feb 17, 2009·Journal of the American Academy of Dermatology·Alan MenterUNKNOWN American Academy of Dermatology
Apr 29, 2009·Health and Quality of Life Outcomes·Murtuza BharmalEric Gemmen
Oct 9, 2009·The Journal of Investigative Dermatology·James T ElderRajan P Nair
Oct 28, 2010·The FEBS Journal·Harald Stenmark
Apr 29, 2011·Journal of the European Academy of Dermatology and Venereology : JEADV·G Murphy, K Reich
Apr 29, 2011·Journal of the European Academy of Dermatology and Venereology : JEADV·A Bewley, B Page
May 26, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·C PaulJ-P Ortonne
May 26, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·S DevauxC Paul
May 15, 2013·Journal of the European Academy of Dermatology and Venereology : JEADV·A BewleyC Ward
Feb 19, 2014·Journal of the European Academy of Dermatology and Venereology : JEADV·J LambertJ Vink
Apr 2, 2014·Journal of the European Academy of Dermatology and Venereology : JEADV·E DaudénK Reich
Citations
Apr 20, 2016·Expert Review of Clinical Pharmacology·Kevin C KinSteven R Feldman
May 11, 2016·Expert Opinion on Drug Delivery·Melissa B HoffmanSteven R Feldman
Aug 18, 2016·Journal of the European Academy of Dermatology and Venereology : JEADV·C PaulC E M Griffiths
Oct 8, 2016·Dermatology and Therapy·Linda Stein GoldMonika Rosen
Apr 19, 2017·Journal of the European Academy of Dermatology and Venereology : JEADV·L IversenD Thaci
Feb 15, 2018·Archives of Dermatological Research·Aleksandra G FlorekApril W Armstrong
Aug 11, 2017·Journal of the European Academy of Dermatology and Venereology : JEADV·C-H HongS Philipp
Jan 18, 2018·Current Medical Research and Opinion·Peter FoleyLasse Ryttig
Aug 9, 2017·Dermatology and Therapy·Siegfried SegaertVincent Descamps
Feb 25, 2020·The Journal of Dermatological Treatment·Siegfried SegaertMelinda Gooderham
Apr 4, 2020·Expert Opinion on Drug Safety·Victoria Amat-Samaranch, Lluís Puig
Jun 2, 2020·Expert Review of Clinical Immunology·Matteo MegnaGabriella Fabbrocini
Aug 1, 2020·The Journal of Dermatology·Hidetoshi TakahashiHidemi Nakagawa
Sep 24, 2020·Advances in Therapy·Linda Stein GoldUNKNOWN PSO-LONG Trial Investigators
Jan 16, 2020·The Journal of Dermatological Treatment·Deepak M W BalakLidia Becla
Feb 27, 2017·American Journal of Clinical Dermatology·Carle PaulMark Lebwohl
Dec 29, 2020·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Melissa KirkbyGary P Moss
Jan 12, 2021·Journal of the European Academy of Dermatology and Venereology : JEADV·M G LebwohlA Jacobson
Jan 16, 2021·Patient Preference and Adherence·Yi ZhaoKazi Deluwar Ahmed
May 5, 2021·The Journal of Dermatological Treatment·Claire BarkPer Svangren
Oct 11, 2021·Journal of the European Academy of Dermatology and Venereology : JEADV·A PinterUNKNOWN trial investigator group
Jan 7, 2021·Dermatology : International Journal for Clinical and Investigative Dermatology·Julia-Tatjana MaulAlexander A Navarini